Literature DB >> 25240809

The effect of osteoporosis management on proximal humeral fracture.

Anshuman Singh1, Annette L Adams2, Raoul Burchette2, Richard M Dell3, Tadashi T Funahashi3, Ronald A Navarro4.   

Abstract

HYPOTHESIS AND
BACKGROUND: Proximal humeral fractures comprise 10% of fractures in the Medicare population. The effect, if any, of treating osteoporosis to prevent these fractures has not been determined. The primary objective is to determine the effectiveness of a systematic osteoporosis screening and treatment program on the hazard of developing a fracture over the treatment period. The secondary aim is to determine demographic risk factors.
METHODS: This is a retrospective cohort study in a health care organization serving 3.3 million members. Individuals selected for dual-energy x-ray absorptiometry screening were (1) women aged 65 years or older; (2) men aged 70 years or older; and (3) individuals aged 50 years or older who have a history of fragility fracture, use glucocorticoids, have a parental history of hip fracture, have rheumatoid arthritis, use alcohol at a high rate, or are cigarette smokers. Treatment consisted primarily of pharmacologic intervention with bisphosphonates.
RESULTS: Individuals diagnosed with osteoporosis had a hazard ratio of 7.43 for sustaining a fracture over the study period. Patients screened with dual-energy x-ray absorptiometry had a hazard ratio of 0.17 whereas those treated medically had a hazard ratio of 0.55 versus untreated controls. Risk factors that significantly increased the risk of a fracture developing included age, female gender, white race, diabetes mellitus, and history of a distal radius fracture. DISCUSSION AND
CONCLUSION: Over the study period, screening and treatment for osteoporosis significantly decreased the hazard ratio for proximal humeral fracture. This information broadens the impact of such programs because current best practices are primarily based on prevention of spine and hip fractures.
Copyright © 2015 Journal of Shoulder and Elbow Surgery Board of Trustees. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DXA scan; Proximal humeral fracture; bisphosphonates; fracture prevention; fragility fracture; osteoporosis

Mesh:

Substances:

Year:  2014        PMID: 25240809     DOI: 10.1016/j.jse.2014.07.005

Source DB:  PubMed          Journal:  J Shoulder Elbow Surg        ISSN: 1058-2746            Impact factor:   3.019


  6 in total

1.  The potential of locking plate with intramedullary fibular allograft to manage proximal humeral fracture with an unstable medial column.

Authors:  Young-Kyu Kim; Suk-Woong Kang; Kyu-Hak Jung; Young-Kwang Oh
Journal:  Arch Orthop Trauma Surg       Date:  2020-09-18       Impact factor: 3.067

2.  The Adequacy of Diagnosis and Treatment for Osteoporosis in Patients with Proximal Humeral Fractures.

Authors:  Tae In Kim; Jun Ha Choi; Sae Hoon Kim; Joo Han Oh
Journal:  Clin Orthop Surg       Date:  2016-08-10

3.  Trends in incidence of proximal humerus fractures, surgical procedures and outcomes among elderly hospitalized patients with and without type 2 diabetes in Spain (2001-2013).

Authors:  Maria Angeles Martinez-Huedo; Rodrigo Jiménez-García; Eduardo Mora-Zamorano; Valentín Hernández-Barrera; Manuel Villanueva-Martinez; Ana Lopez-de-Andres
Journal:  BMC Musculoskelet Disord       Date:  2017-12-11       Impact factor: 2.362

4.  Cement augmentation of humeral head screws reduces early implant-related complications after locked plating of proximal humeral fractures.

Authors:  J Christoph Katthagen; O Lutz; C Voigt; H Lill; A Ellwein
Journal:  Obere Extrem       Date:  2018-01-30

5.  How age and gender influence proximal humerus fracture management in patients older than fifty years.

Authors:  Akshar H Patel; J Heath Wilder; Sione A Ofa; Olivia C Lee; Michael C Iloanya; Felix H Savoie; William F Sherman
Journal:  JSES Int       Date:  2021-12-17

6.  Epidemiology and patho-anatomical pattern of 2,011 humeral fractures: data from the Swedish Fracture Register.

Authors:  Carl Bergdahl; Carl Ekholm; David Wennergren; Filip Nilsson; Michael Möller
Journal:  BMC Musculoskelet Disord       Date:  2016-04-12       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.